Journalartikel
Autorenliste: Grummet, Jeremy; Gorin, Michael A.; Popert, Rick; O'Brien, Tim; Lamb, Alastair D.; Hadaschik, Boris; Radtke, Jan Philipp; Wagenlehner, Florian; Baco, Eduard; Moore, Caroline M.; Emberton, Mark; George, Arvin K.; Davis, John W.; Szabo, Richard J.; Buckley, Roger; Loblaw, Andrew; Allaway, Matthew; Kastner, Christof; Briers, Erik; Royce, Peter L.; Frydenberg, Mark; Murphy, Declan G.; Woo, Henry H.
Jahr der Veröffentlichung: 2020
Seiten: 62-65
Zeitschrift: Prostate Cancer and Prostatic Diseases
Bandnummer: 23
Heftnummer: 1
ISSN: 1365-7852
eISSN: 1476-5608
Open Access Status: Hybrid
DOI Link: https://doi.org/10.1038/s41391-020-0204-8
Verlag: Springer Nature [academic journals on nature.com]
Zitierstile
Harvard-Zitierstil: Grummet, J., Gorin, M., Popert, R., O'Brien, T., Lamb, A., Hadaschik, B., et al. (2020) "TREXIT 2020": why the time to abandon transrectal prostate biopsy starts now, Prostate Cancer and Prostatic Diseases, 23(1), pp. 62-65. https://doi.org/10.1038/s41391-020-0204-8
APA-Zitierstil: Grummet, J., Gorin, M., Popert, R., O'Brien, T., Lamb, A., Hadaschik, B., Radtke, J., Wagenlehner, F., Baco, E., Moore, C., Emberton, M., George, A., Davis, J., Szabo, R., Buckley, R., Loblaw, A., Allaway, M., Kastner, C., Briers, E., ...Woo, H. (2020). "TREXIT 2020": why the time to abandon transrectal prostate biopsy starts now. Prostate Cancer and Prostatic Diseases. 23(1), 62-65. https://doi.org/10.1038/s41391-020-0204-8
Schlagwörter
COMPLICATIONS; TRANSPERINEAL
